Autres langues Genovis AB

Actions

GENO

SE0002485979

Temps Différé Nasdaq Stockholm Autres places de cotation 10:00:07 21/05/2024			Varia. 5j.	Varia. 1 janv.
37,5 ^SEK	+1,35%		+28,64%	-27,88%

15/05	Genovis AB (publ.) publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
14/03	Carthesian Therapeutics met fin à l'accord de licence de Genovis AB (Publ.)	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

GenovisQ1 2024 - Financials in line with expectations, strong outlook	16/05
Interim Report January - March 2024	15/05
Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Genovis Annual Report 2023 published	24/04
NOTICE CONVENING THE 2024 ANNUAL GENERAL MEETING	09/04
Carthesian Therapeutics terminates Genovis Licence Agreement	14/03
Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement	14/03
Genovis Q4 2023 - Soft ending but promising start	19/02
Genovis AB (publ.) Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Year-end report January-December 2023	15/02
Genovis AB (publ.) Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Genovis to Get $1 Million Milestone Payment for Xork Development	13/02
Genovis to receive USD 1 million in milestone compensation related to the development of the Xork™ enzyme	13/02
Genovis AB changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11
Genovis Q3 2023 - Solid growth and profitability, Xork timeline remains on track	16/11
Genovis AB (publ.) Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Genovis Q2 2023 - Strong growth and expanding EBIT margin	25/08/23
Half-Yearly Report January-June 2023	24/08/23
Genovis AB (publ.) Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Genovis launch Innovative IgM-Specific Protease with Wide-Ranging Applications in Life Science Markets	02/06/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Genovis AB

Actions

GENO

SE0002485979

Autres langues

Filtres